MDS experts, Dr Alan List and Dr David Sallman, provide an overview of the use of
erythropoietin-stimulating agents (ESAs) for
myelodysplastic syndromes (
MDS). ESAs stimulate the bone marrow to help make red blood cells. They describe how ESAs are given, how often they are used, and how long the benefits typically last.
-
Share with family and friends:
Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about MDS which will help other patients, caregivers and families.